COMPOUNDS AND PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE AND ISCHEMIC BRAIN DISEASES

The invention relates to peptides comprising phycocyanobilin (PCB), as well as to the use of said peptides and PCB in medicine owing to the neuroprotective and/or neurogenerative effects thereof that have been identified. In addition, the invention relates to pharmaceutical combinations of said pept...

Full description

Saved in:
Bibliographic Details
Main Authors PARDO ANDREU, GILBERTO LAZARO, GUILLEN NIETO, GERARDO ENRIQUE, LOPEZ SAURA, PEDRO ANTONIO, PAVON FUENTES, NANCY, LLOPIZ ARZUAGA, ALEXEY, MUSACCHIO LASA, ALEXIS, RODRIGUEZ JIMENEZ, EFRAIN, BESADA PEREZ, VLADIMIR ARMANDO, PENTON ROL, GISELLE, PENTON ARIAS, EDUARDO, MARIN PRIDA, JAVIER, GONZALEZ LOPEZ, LUIS JAVIER
Format Patent
LanguageEnglish
French
Published 07.01.2020
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention relates to peptides comprising phycocyanobilin (PCB), as well as to the use of said peptides and PCB in medicine owing to the neuroprotective and/or neurogenerative effects thereof that have been identified. In addition, the invention relates to pharmaceutical combinations of said peptides and PCB with proteins or other peptides which, owing to the synergistic effect thereof, are suitable for use in the treatment of diseases of the central nervous system involving neurodegenerative and ischemic damage. La présente invention concerne des peptides comprenant de la phycocyanobiline (FCB), ainsi que l'utilisation à des fins médicales desdits peptides et de la FCB, compte tenu de leurs effets neuroprotecteurs et/ou neurorégénérateurs identifiés. En outre, l'invention concerne des combinaisons pharmaceutiques desdits peptides et de la FCB avec des protéines ou d'autres peptides qui, du fait de leur effet synergique, sont appropriés pour le traitement de maladies du système nerveux central avec lésion ischémique et neurodégénérative.
Bibliography:Application Number: CA20122838496